about
Frequency of adverse events after vaccination with different vaccinia strainsSmallpox vaccines for biodefense: need and feasibilitySmallpox vaccine: the good, the bad, and the ugly.Risks of serious complications and death from smallpox vaccination: a systematic review of the United States experience, 1963-1968The Future of Smallpox Vaccination: is MVA the key?Clinical development of Ebola vaccinesPoxvirus vectors as HIV/AIDS vaccines in humansEthics, economics, and the use of primaquine to reduce falciparum malaria transmission in asymptomatic populationsEstimating the Size of the U.S. Population at Risk of Severe Adverse Events from Replicating Smallpox Vaccine.Comparison of smallpox outbreak control strategies using a spatial metapopulation model.Bioterrorism: pivotal clinical issues. Consensus review of the Society of Infectious Diseases Pharmacists.Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses.New generation smallpox vaccines: a review of preclinical and clinical data.Identification of polymerase and processivity inhibitors of vaccinia DNA synthesis using a stepwise screening approachA randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE.What the acute care physician needs to know about bioterrorism.Kinetics of serum cytokines after primary or repeat vaccination with the smallpox vaccineHuman antibody responses to the polyclonal Dryvax vaccine for smallpox prevention can be distinguished from responses to the monoclonal replacement vaccine ACAM2000.Control of vaccinia virus skin lesions by long-term-maintained IFN-gamma+TNF-alpha+ effector/memory CD4+ lymphocytes in humans.Highly attenuated vaccinia virus mutants for the generation of safe recombinant virusesACAM2000: the new smallpox vaccine for United States Strategic National Stockpile.Steroid hormone synthesis by a vaccinia enzyme: a new type of virus virulence factorVaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice.An attenuated LC16m8 smallpox vaccine: analysis of full-genome sequence and induction of immune protection.Unpolarized release of vaccinia virus and HIV antigen by colchicine treatment enhances intranasal HIV antigen expression and mucosal humoral responses.Lung involvement in progressive vacciniaA quantitative rabbit model of vaccinia keratitis.Kinetics of immune cell infiltration in vaccinia virus keratitis.Smallpox vaccine with integrated IL-15 demonstrates enhanced in vivo viral clearance in immunodeficient mice and confers long term protection against a lethal monkeypox challenge in cynomolgus monkeys.An "opting in" paradigm for kidney transplantation.Safety and immunogenicity of modified vaccinia Ankara (ACAM3000): effect of dose and route of administration.Risks and benefits of preexposure and postexposure smallpox vaccination.Life-threatening dermatosesMutations in modified virus Ankara protein 183 render it a non-functional counterpart of B14, an inhibitor of nuclear factor kappaB activation.Smallpox vaccine safety is dependent on T cells and not B cellsEvaluation of therapeutic interventions for vaccinia virus keratitisA novel naturally occurring tandem promoter in modified vaccinia virus ankara drives very early gene expression and potent immune responsesVaccines for Category A bioterrorism diseases.[Johann Gottfried Bremser (1767-1827) as a protagonist of the cowpox vaccine].Immune correlates of protection against yellow fever determined by passive immunization and challenge in the hamster model.
P2860
Q21092385-5F64C67B-20F7-4D69-AFDF-C5DD26524DC9Q22305942-4F444330-4B94-40F8-9D52-FD689D644B21Q24520563-7692A9D5-7059-4FBB-B1FB-8D942787F070Q24799168-910F7D96-0094-465E-8AFC-570D415ECFF4Q24801195-F0E8A55B-2F98-4B11-A28B-658AAE48ECA1Q26775792-750CC88D-344A-4E17-893B-D6B6A918C31CQ26995078-0D8FA4E4-061C-40D2-AE50-9B8F9A1BE568Q28542069-0A68242B-6146-42A9-9ADB-58BE68F6E163Q30151714-7D1735EB-FDB4-4200-905E-5EE1853248FCQ30230157-288A2F92-42C8-47C0-8625-B0660EEDBFAAQ30233435-6ECAEB41-804A-482C-B4A3-B47FF2BF7DB1Q30449492-2AF2D707-CF91-48B9-B299-9BB9028CAE76Q31147081-2CAC504B-381F-491A-8348-C5F987DAF6B7Q33351233-CEE02441-5DA8-4571-8AD4-8DB08BF982CFQ33624420-0ECC0DE5-F60A-4EB6-A292-F24FE965BF5BQ33644981-2D6D1332-BAC4-4294-B26D-9AC6475BC612Q33729509-96F66428-D74C-4AA2-B267-21FB1428B04EQ33743444-EA39168C-A0CF-48E6-A477-FBFB7CAC8801Q33815680-3D154666-3168-449F-80DE-2FAA810229C8Q33838030-D8DE74AD-B013-4A8D-9456-A9FB9289402CQ33892570-2824021B-2192-44E6-ABFB-2960E07F8659Q33937787-31E1204D-FF1B-43C5-B8F7-8EABA2D64560Q33987410-9CC6262B-76F6-431D-8C28-CEC57727C1C6Q33987538-3EC9527A-1016-4A5D-A473-4C5A22E002CEQ34026061-936B9810-CDF5-4CC4-8792-08854968F2D5Q34109604-B6AF8922-D271-4458-8CCE-3A8B3C211117Q34135490-B816504A-C929-448B-A156-1BFD21A66F1CQ34135568-B1393EA0-9478-4581-B105-A47286454000Q34188464-D6B46E33-0BCF-462C-9B0D-492A67D112B0Q34455000-F3B9FAFB-4BC5-4BBC-972C-1B57B859AD4BQ34470311-1132493A-9918-4492-AA70-95FD28697036Q34560088-50F4C9EC-A209-46B3-A323-CC80B556F5C4Q34584766-5EBFE48C-A51C-4A4F-A94A-267C26FDD35EQ34641590-06B3AB07-2BDB-46CE-8E08-536D4CFB0789Q34743303-0A34808C-3A59-453D-923E-EA17CE99910BQ34772694-6BA34CF3-2967-4648-A744-8B7ADED124E4Q34952043-9F8C69D6-3A10-4189-A670-FAF211025B58Q35040844-520C34E2-5E11-4374-9992-A40016DC11C2Q35046369-36A7576E-218C-4B43-8080-E96E5A205071Q35141448-86DFEF9E-0C27-4A5D-8291-F98519D7688A
P2860
description
1969 nî lūn-bûn
@nan
1969年の論文
@ja
1969年学术文章
@wuu
1969年学术文章
@zh-cn
1969年学术文章
@zh-hans
1969年学术文章
@zh-my
1969年学术文章
@zh-sg
1969年學術文章
@yue
1969年學術文章
@zh
1969年學術文章
@zh-hant
name
Complications of smallpox vaccination, 1968.
@en
Complications of smallpox vaccination, 1968.
@nl
type
label
Complications of smallpox vaccination, 1968.
@en
Complications of smallpox vaccination, 1968.
@nl
prefLabel
Complications of smallpox vaccination, 1968.
@en
Complications of smallpox vaccination, 1968.
@nl
P2093
P1476
Complications of smallpox vaccination, 1968.
@en
P2093
P304
P356
10.1056/NEJM196911272812201
P407
P577
1969-11-01T00:00:00Z